Statistics on Biotechnology Use Results by fields of operation Company sector. Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production Unidades: specified in variables Total Main Secondary dwellings Tool Companies that carry out R&D in Biotechnology 1.198 644 171 383 %Companies according to biotechnology used: Genetic code 33,3 40,9 24 24,8 %Companies according to biotechnology used: Functional units 39,8 44,2 38,1 33,3 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 24,2 28,8 14,2 20,8 %Companies according to biotechnology used: Bioprocesses 49,6 42,6 52,3 60,2 %Companies according to biotechnology used: Sub-cellular organisms 6,7 8,7 5,8 3,6 %Companies according to biotechnology used: Bio-computing 23,9 33,5 13 12,7 %Companies according to biotechnology used: Nanobiotechnology 11,2 14,5 13,4 4,7 %Companies according to biotechnology used: Other 14,6 14,4 19,9 12,6 %Company by field(s) of ultimate application of biotechnology use: Human Health 47,3 62,8 35,1 26,7 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 19,4 21,7 17,8 16,2 %Company by field(s) of ultimate application of biotechnology use: Food products 32,5 26,1 30,5 44,1 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 24,1 20,7 31,8 26,5 %Company by field(s) of ultimate application of biotechnology use: Environment 14,9 12,8 28,9 12,3 %Company by field(s) of ultimate application of biotechnology use: Industry 12,8 12,8 17,8 10,6 Personnel in R&D in biotechnology (no. of persons) 13.615 8.038 1.812 3.765 Personnel in R&D in biotechnology (no. of persons): Researchers 7.436 4.561 1.031 1.845 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 6.178 3.477 781 1.920 Personnel in R&D in biotechnology (no. of persons): women 7.639 4.718 918 2.003 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 4.095 2.582 540 973 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 3.544 2.136 378 1.030 Personnel in R&D in biotechnology (FTE) 9.365,2 5.985,1 1.120,4 2.259,7 Personnel in R&D in biotechnology (FTE): Researchers 5.410,6 3.550,1 695,8 1.164,8 Personnel in R&D in biotechnology (FTE): Technicians and assistants 3.954,6 2.435 424,6 1.095 Personnel in R&D in biotechnology (FTE): women 5.385,8 3.561,4 597,6 1.226,7 Personnel in R&D in biotechnology (FTE): (women) Researchers 3.032,9 2.028,8 372,1 632 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 2.352,9 1.532,6 225,6 594,7 Internal expenditure on R&D (thousands of euros) 940.230 671.106 84.012 185.112 1) By nature of the expense: Current expenses 871.813 624.784 75.356 171.672 1.1) Remuneration to researchers 284.936 194.490 33.985 56.460 1.2) Remuneration to technicians and assistants 148.254 96.140 14.239 37.875 1.3) Other current expenses 438.623 334.154 27.132 77.337 2) By nature of the expense: Capital expenses 68.417 46.322 8.656 13.440 2.1) Land and buildings 11.763 6.204 2.874 2.685 2.2) Equipment and instruments 39.641 24.588 5.378 9.674 2.3) Acquisition of specific R+D software 2.831 1.735 319 777 2.4) Otros productos de propiedad intelectual específicos para I+D 14.183 13.794 85 303 1.1) By origin of the funds: Own funds 577.287 421.224 39.177 116.886 1.2) By origin of the funds: From companies 142.672 96.993 8.211 37.467 1.3) By origin of the funds: Public Administration funds 102.630 64.741 18.219 19.670 1.4) By origin of the funds: From Universities 457 453 0 5 1.5) By origin of the funds: From non profit private institutions 9.631 8.141 195 1.294 1.6) By origin of the funds: Foreign funds 107.553 79.554 18.210 9.790 Purchase of R&D services in biotechnology (thousands of euros) 114.839 87.621 15.855 11.363 Purchase of R&D services in biotechnology (thousands of euros): In Spain 69.258 50.862 13.073 5.324 Purchase of R&D services in biotechnology (thousands of euros): Abroad 45.581 36.760 2.782 6.039 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 41,8 48,5 36,1 33 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 12 9,3 16,6 14,5 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 13,1 11,5 15 14,8 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 10,7 10,8 10,3 10,5 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets 15 16 15 14 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels 16 18 16 12 %Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception 16 15 19 17 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 41 38 31 %Companies that consider the following obstacles as very important considering biotechnology development : Time / cost 51 56 50 43 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19 17,4 18,9 21,8 % Companies that have requested biotechnology patents 18 26 14 8 Number of patents requested 643 471 54 118 % Companies with income of an international origin related to biotechnological activities 24,4 30,7 15,3 17,9 % Turnover representing income of an international origin related to biotechnological activities 1,6 8,5 0 1,5 % Income of of an international origin related to biotechnological activities distributed in: Income received from the EU 56 61 60 40 % Income of of an international origin related to biotechnological activities distributed in: Income received from other countries 44 39 40 60 % Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services 70 79 73 44 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 23,9 18,5 0,5 41,4 % Income of an international origin related with activities according to the classification: Operating source abroad 5,3 1,9 26,7 14,5 % Income of an international origin related with activities according to the classification: Other 0,6 0,8 0 0,1 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute